AddictionNews

Latest developments in causes and treatments

AddictionNews

AddictionNews

GLP-1

Are GLP-1 Drugs the Death of Desire?

GLP-1 drugs such as Ozempic, Monjourno and Wegovy appear to have the ability to suppress all desire, sometimes with negative consequences.

The Use of GLP-1 Drugs for Nicotine Use Disorder and Smoking Cessation

More and more studies show GLP-1 drugs work for smoking cessation, alcohol use disorder and opioid use disorder, but researchers aren’t sure how.

Testing GLP-1 Drugs for Substance Use Disorders

Limited human trials of GLP-1 drugs for substance use disorders indicate they might not work well for non-obese individuals.

Does Ozempic Cause Weight Loss By Making People Sick?

We examine anecdotal reports and scientific evidence concerning gastrointestinal discomfort as a result of taking GLP-1 drugs.

Why Isn’t Big Pharma Investing in GLP-1 Trials for Substance Use Disorders?

There’s a noticeable lack of pharmaceutical company trials of GLP-1 drugs as treatments for substance use disorders.

Does Ozempic Cause Weight Loss by Impacting the Brain or the Gut?

A study from The Netherlands examines the impacts of GLP-1 agonists on the central nervous system using fMRI.